In the last 10 years since the time of my PhD in Tissue Engineering and Regenerative Medicine, I have been supporting the preclinical development of new therapies in Pharma, Biotech and Universities Europe-wide. We have been experiencing tremendous shifts in the way research is performed, from the advent of AI to the introduction of the 3R and the reduction of animal studies in favour of organ-on-a-chip and advanced 3D culture technologies. In my academic career I had the opportunity to make valuable experiences all these areas and I now have the privilege to assist scientists in their practical applications. With an increasing globalization in the Life Sciences, more international companies join the market everyday, adding to the incredible and sometimes confusing amount of information available. I have funded Sellomics in the belief that researchers need clarity and a reliable and knowledgeable partner at their side that would help them reach their most ambitious goals. Ultimately, our mission is to bring innovative research tools and solutions to researchers to help bringing new therapies to patients.